DEVELOPMENT OF IMAGE ENHANCEMENT RADIOPHARMACEUTICALS FOR THERAPY

用于治疗的图像增强放射性药物的开发

• 批准号: 8168699
• 负责人: ROBERT H MACH
• 金额: $ 0.41万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-03-10 至 2010-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8168699
• 关键词: Arts; Computer Retrieval of Information on Scientific Projects Database; Cyclotrons; Development; Equipment; Faculty; Funding; Grant; Image; Image Enhancement; Image Enhancement Agent; Institutes; Institution; Investigation; Laboratories; Linear Accelerator Radiotherapy Systems; Magnetic Resonance Imaging; Photons; Positron; Postdoctoral Fellow; Production; Quality Control; Radioisotopes; Radiology Specialty; Radiopharmaceuticals; Research; Research Personnel; Resources; Science; Source; Targeted Radiotherapy; United States National Institutes of Health; Universities; Washington; graduate student; medical schools; member; single photon emission computed tomography

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This laboratory carries out research on the development of image enhancement agents and radiopharmaceuticals for therapy. The laboratory is in the Division of Radiological Sciences in the Mallinckrodt Institute, Department of Radiology, Washington University Medical School and has eight faculty members, five post doctoral Research Associates, two graduate students and approximately 16 support staff. The laboratory operates two cyclotrons and a linear accelerator for radionuclide production and maintains state-of-the-art equipment for synthesis, separation and quality control of agents for imaging and therapy. Research is carried out in development of both inorganic and organic compounds for positron emission tomographic (PET), single photon emitted tomographic (SPECT) and magnetic resonance (MR) imaging applications. Radiopharmaceuticals are also developed for the investigation of targeted radiotherapy.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 该实验室开展图像增强剂和治疗用放射性药物的开发研究。该实验室位于华盛顿大学医学院放射系马林克罗特研究所放射科学部，拥有 8 名教职人员、5 名博士后研究员、2 名研究生和大约 16 名支持人员。该实验室拥有两台回旋加速器和一台直线加速器用于放射性核素生产，并拥有最先进的设备，用于成像和治疗试剂的合成、分离和质量控制。研究开发用于正电子发射断层扫描 (PET)、单光子发射断层扫描 (SPECT) 和磁共振 (MR) 成像应用的无机和有机化合物。放射性药物也被开发用于靶向放射治疗的研究。